N/A
Completed N=115
QuitGuide for American Indians: Aims 2 & 3
Source: ClinicalTrials.gov NCT05447156 ↗Enrolled (actual)
115
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcomePrimary: Frequency of App Use — 15.3; 14.9; 4.3; 3.7 App initiations per day
Summary
Aim 3: To test feasibility, acceptability, and preliminary efficacy of the tailored QuitGuide for smoking cessation among AIs.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Frequency of App Use |
15.3; 14.9; 4.3; 3.7 | — |
| SECONDARY Study Attrition Measured as Percentage of Randomized Participants That Complete the Final Phone Interview at 5 Weeks |
55; 53 | — |
| SECONDARY Frequency of Returning Saliva Sample by 2 Weeks Post the Week 5 Interview |
35; 31 | — |
| SECONDARY Usability of App Design Measured Using System Usability Scale (SUS) |
72.4; 71.9 | — |
| SECONDARY Acceptability of Overall App |
5.6; 4.9 | — |
| SECONDARY Fit of App With Culture |
3.9; 3.1 | — |
Eligibility Criteria
Inclusion Criteria
- American Indian person based on self-report
- Age ≥ 18 years
- Interested in quitting smoking
- Smoke ≥ 3 commercial tobacco cigarette per day (CPD) in the past 30 days
o Use of other commercial tobacco products (e.g., e-cigarettes) is permitted if they report cigarettes being their primary product
- Smartphone ownership with the ability to download applications and sufficient data to complete research procedures
Exclusion Criteria
- New or change in pharmacotherapy for smoking cessation (includes: nicotine gum, patch, lozenge, inhaler OR medications Chantix/Wellbtrutin/Zyban/Bupropion) in past month
- Does not speak or read English
Data sourced from ClinicalTrials.gov (NCT05447156). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.